Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
Select Page
Reduction of Eyedrop Volume for Topical Ophthalmic Medications with the Nanodropper Bottle Adaptor

Reduction of Eyedrop Volume for Topical Ophthalmic Medications with the Nanodropper Bottle Adaptor

by Xcellerant Ventures | Apr 6, 2024 | Portfolio Company News

Origionally posted on National Library of Medicine: https://pubmed.ncbi.nlm.nih.gov/37056302/ Abstract Purpose: To determine the drop volume and total number of dispensed drops using the Nanodropper eyedrop bottle adaptor (Nanodropper, Inc.) compared to drops...
UK Regulatory Approval for DL Precise™ Software

UK Regulatory Approval for DL Precise™ Software

by Xcellerant Ventures | Mar 5, 2024 | Portfolio Company News

Origionally posted on DeepLook Medical’s website: https://www.deeplookmedical.com/post/deeplook-medical-s-dl-precise-software-secures-regulatory-approval-in-the-uk   New Haven, CT – March 6,  2024: DeepLook Medical, a Connecticut-based technology firm,...
New Software Tool Takes on Institutionalized Racism in Health Care

New Software Tool Takes on Institutionalized Racism in Health Care

by Xcellerant Ventures | Feb 26, 2024 | Portfolio Company News

Origionally posted on Cronkite News: https://cronkitenews.azpbs.org/2024/02/26/trulite-health-software-addresses-health-disparities-mayo-clinic-arizona/   PHOENIX – An expecting mother goes for her first ultrasound with a new doctor. During the appointment, the...
Twin Cities Business Podcast, Episode 128: Nanodropper Co-Founder Allisa Song

Twin Cities Business Podcast, Episode 128: Nanodropper Co-Founder Allisa Song

by Xcellerant Ventures | Feb 21, 2024 | Portfolio Company News

Origionally posted on Twin Cities Business: https://tcbmag.com/podcast/allisa-song/   By the time Allisa Song started medical school at Mayo Clinic in 2018, she was already the founder of an active medical device startup company called Nanodropper. The idea came...
Big Wins, Strategic Moves and Growth for Ross Bundy’s CRISPR QC and Gene Editing

Big Wins, Strategic Moves and Growth for Ross Bundy’s CRISPR QC and Gene Editing

by Xcellerant Ventures | Jan 28, 2024 | Portfolio Company News

Origionally posted on MSN.com: https://www.msn.com/en-us/news/other/big-wins-strategic-moves-and-growth-for-ross-bundy%E2%80%99s-crispr-qc-and-gene-editing/ar-BB1hnksW?disableErrorRedirect=true&infiniteContentCount=0 The field of CRISPR editing has reached a...
« Older Entries
Next Entries »

Recent Posts

  • TruLite Health Partners with Lee Health to Elevate Health Equity Strategy
  • TruLite Health Selected for Microsoft Pegasus Program
  • Xcellerant Ventures Leads DeepLook Medical’s Series A Round
  • DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
  • Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023